We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $133B
1-Year Est. Return 43.5%
This Fund
S&P 500
This Quarter Est. Return
+26.39%
1 Year Est. Return
+43.5%
3 Year Est. Return
+132.19%
5 Year Est. Return
+175.35%
10 Year Est. Return
+672.4%
AUM
$133B
AUM Growth
+$15.7B
Cap. Flow
-$1.75B
Cap. Flow %
-1.32%
Top 10 Hldgs %
30.35%
Holding
4,370
New
224
Increased
1,883
Reduced
1,827
Closed
183

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$212M
2
MSFT icon
Microsoft
MSFT
+$156M
3
AMZN icon
Amazon
AMZN
+$142M
4
HON icon
Honeywell
HON
+$119M
5
NVDA icon
NVIDIA
NVDA
+$94.5M

Sector Composition

Rank Sector Weight
1 Technology 35.1%
2 Financials 11.93%
3 Industrials 10.35%
4 Consumer Discretionary 9.64%
5 Healthcare 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EHTH icon
3401
eHealth
EHTH
$24.2M
$20K ﹤0.01%
13,454
-22,727
-63% -$38.1K
TTEC icon
3402
TTEC Holdings
TTEC
$60.6M
$19.9K ﹤0.01%
10,242
-13,630
-57% -$35.2K
RENT
3403
Rent the Runway
RENT
$56.7M
$19.8K ﹤0.01%
+6,273
New +$26.6K
NOAH
3404
Noah Holdings
NOAH
$544M
$19.7K ﹤0.01%
1,977
– –
CAN
3405
Canaan Creative
CAN
$276M
$19.6K ﹤0.01%
68,304
+55,445
+431% +$24.1K
CLPR
3406
Clipper Realty
CLPR
$53.6M
$19.2K ﹤0.01%
7,042
-10,509
-60% -$33.1K
KULR icon
3407
KULR Technology Group
KULR
$113M
$18.8K ﹤0.01%
4,935
-39,109
-89% -$130K
SHIM icon
3408
Shimmick
SHIM
$130M
$18.4K ﹤0.01%
+4,028
New +$17.8K
KZIA
3409
Kazia Therapeutics
KZIA
$149M
$18.2K ﹤0.01%
1,296
-106
-8% -$1.29K
ATYR
3410
aTyr Pharma
ATYR
$29.9M
$18.2K ﹤0.01%
30,412
-72,734
-71% -$47.5K
DIDI
3411
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
$18K ﹤0.01%
5,373
– –
IVA
3412
Inventiva
IVA
$796M
$17.7K ﹤0.01%
4,672
+1,810
+63% +$8.7K
WDH
3413
Waterdrop
WDH
$374M
$17.4K ﹤0.01%
15,359
– –
SKIN icon
3414
SkinHealth Systems
SKIN
$86.5M
$17.4K ﹤0.01%
25,079
-102,048
-80% -$78K
IONR
3415
Ioneer
IONR
$254M
$17.1K ﹤0.01%
3,950
+230
+6% +$930
XTLB
3416
XTL Biopharmaceuticals
XTLB
$5.41M
$17K ﹤0.01%
6,228
+241
+4% +$621
PED icon
3417
PEDEVCO
PED
$174M
$16.7K ﹤0.01%
+1,244
New +$18.1K
AVAL icon
3418
Grupo Aval
AVAL
$5.89B
$16.5K ﹤0.01%
3,288
– –
MLCO icon
3419
Melco Resorts & Entertainment
MLCO
$1.8B
$16.5K ﹤0.01%
3,125
-370
-11% -$2.07K
GRSD
3420
Grandstand Ltd
GRSD
$55.9M
$16.5K ﹤0.01%
8,666
-11,847
-58% -$36.9K
MTL.PR
3421
DELISTED
Mechel PAO American Depositary Shares (each representing one-half of a Preferred Share)
MTL.PR
$16.4K ﹤0.01%
13,618
– –
JMIA
3422
Jumia Technologies
JMIA
$919M
$16.3K ﹤0.01%
2,313
+820
+55% +$5.83K
HURA
3423
TuHURA Biosciences
HURA
$134M
$16.1K ﹤0.01%
6,863
-13,867
-67% -$32.3K
IMMP
3424
Immutep
IMMP
$38.8M
$15.6K ﹤0.01%
37,536
+15,483
+70% +$6.73K
DAO
3425
Youdao
DAO
$1.77B
$15K ﹤0.01%
1,219
– –

Similar funds

RhumbLine Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, RhumbLine Advisers held 4,370 positions worth $133B, up 13% from $117B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

RhumbLine Advisers's Q2 2026 filing shows 224 new, 1,883 increased, 1,827 reduced and 183 closed positions. Its largest new stake was Honeywell Aerospace: 529,091 shares worth $117M. The largest sale was Apple, an estimated $212M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 31% a quarter earlier, followed by Financials and Industrials.

  • RhumbLine Advisers's largest Q2 2026 buy was Honeywell Aerospace: 529,091 shares worth $117M.
  • RhumbLine Advisers added most to Marvell Technology in Q2 2026, an estimated $117M increase.
  • RhumbLine Advisers's biggest Q2 2026 reduction was Apple, cutting an estimated $212M.
  • RhumbLine Advisers fully exited Coterra Energy in Q2 2026, selling an estimated $53.5M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $133B portfolio in Q2 2026.
  • RhumbLine Advisers opened 224 new positions and closed 183 in Q2 2026.
  • RhumbLine Advisers's portfolio value rose 13% quarter-over-quarter to $133B.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.